量化含α-突触核蛋白细胞外囊泡的帕金森病敏感诊断 assay 开发
本研究开发了一种基于 Apogee 纳米流式细胞术的快速灵敏 assay,用于量化脑脊液中含α-突触核蛋白(α-syn)的细胞外囊泡(EVs),并在 170 例帕金森病(PD)患者和 131 名健康对照(HCs)中评估其诊断潜力。结果显示,PD 患者脑脊液中总α-syn阳性及聚集α-syn阳性 EV 亚群占全部 EV 的比例显著低于 HCs(p < 0.0001),两亚群联合诊断的曲线下面积为 0.819,灵敏度 80%,特异度 71%。
要点
- 脑脊液总α-syn阳性及聚集α-syn阳性 EV 亚群比例在 PD 患者中显著低于健康对照。
- 两 EV 亚群联合诊断 PD 的 AUC 为 0.819,灵敏度 80%,特异度 71%。
- 该 assay 基于纳米流式细胞术,可快速灵敏量化脑脊液 EV 亚群。
核心结论
- 脑脊液中总α-syn阳性及聚集α-syn阳性 EV 亚群可能有助于 PD 诊断。
- 该研究提供 III 级证据表明上述 EV 亚群可识别 PD 患者。
研究设计与样本
- 横断面多中心研究,纳入 170 例 PD 患者和 131 名年龄性别分布相似的健康对照。
- 受试者来自华盛顿大学和俄勒冈健康与科学大学现有中心研究。
- 采用基于 Apogee 纳米流式细胞术的高特异、灵敏、快速 assay 量化脑脊液 EV。
主要发现
- PD 患者与健康对照间脑脊液总 EV 的数量和大小分布无显著差异。
- PD 患者脑脊液中总α-syn阳性及聚集α-syn阳性 EV 占全部 EV 的比例均显著低于健康对照(p < 0.0001)。
- 各 EV 亚群的诊断灵敏度和特异度均优于直接免疫 assay 测量的总脑脊液α-syn。
关键数值与推荐
- 两 EV 亚群联合诊断 PD 的曲线下面积 0.819,灵敏度 80%,特异度 71%。
- 总α-syn阳性及聚集α-syn阳性 EV 比例在 PD 与健康对照间差异的 p < 0.0001。
临床怎么用
- 该 assay 可作为 PD 诊断的辅助工具,尤其适用于需要脑脊液生物标志物支持的病例。
- 联合检测总α-syn阳性与聚集α-syn阳性 EV 亚群可提高诊断准确性。
局限性
- 研究为横断面设计,未报告纵向随访或早期/鉴别诊断性能。
- 样本来自两个中心 existing center studies,外推性需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To develop a reliable and fast assay to quantify the α-synuclein (α-syn)-containing extracellular vesicles (EVs) in CSF and to assess their diagnostic potential for Parkinson disease (PD). METHODS: A cross-sectional, multicenter study was designed, including 170 patients with PD and 131 healthy controls (HCs) with a similar distribution of age and sex recruited from existing center studies at the University of Washington and Oregon Health and Science University. CSF EVs carrying α-syn or aggregated α-syn were quantified using antibodies against total or aggregated α-syn, respectively, and highly specific, sensitive, and rapid assays based on the novel Apogee nanoscale flow cytometry technology. RESULTS: No significant differences in the number and size distribution of total EVs between patients with PD and HCs in CSF were observed. When examining the total α-syn-positive and aggregated α-syn-positive EV subpopulations, the proportions of both among all detected CSF EVs were significantly lower in patients with PD compared to HCs (p < 0.0001). While each EV subpopulation showed better diagnostic sensitivity and specificity than total CSF α-syn measured directly with an immunoassay, a combination of the 2 EV subpopulations demonstrated a diagnostic accuracy that attained clinical relevance (area under curve 0.819, sensitivity 80%, specificity 71%). CONCLUSION: Using newly established, sensitive nanoscale flow cytometry assays, we have demonstrated that total α-syn-positive and aggregated α-syn-positive EVs in CSF may serve as a helpful tool in PD diagnosis. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that total and aggregated α-syn-positive EVs in CSF identify patients with PD.
引用
- Hong Z, Tian C, Stewart T, et al. Development of a Sensitive Diagnostic Assay for Parkinson Disease Quantifying α-Synuclein-Containing Extracellular Vesicles. Neurology. 2021. PMID: 34032594. doi:10.1212/WNL.0000000000011853
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。